Hudson Bay Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.1M | Buy |
|
|||||
|
2025
Q2 | $759K | Buy |
|
|||||
|
2025
Q1 | $672K | Buy |
|
|||||
|
2024
Q4 | $524K | Sell |
|
|||||
|
2024
Q3 | $593K | Buy |
|
|||||
|
2024
Q2 | $338K | Buy |
|
|||||
|
2024
Q1 | $299K | Sell |
|
|||||
|
2023
Q4 | $789K | Buy |
|
|||||
|
2023
Q3 | $306K | Sell |
|
|||||
|
2023
Q2 | $822K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $977K | Sell |
|
|||||
|
2022
Q1 | $1.43M | Buy |
|